A carregar...
Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy
Immunotherapy with checkpoint inhibitors has revolutionized cancer therapy and is now the standard treatment for several different types of cancer, supported by favorable outcomes and good tolerance. However, it is linked to multiple immune manifestations, referred to as immune-related adverse event...
Na minha lista:
| Publicado no: | Gastroenterol Rep (Oxf) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7034236/ https://ncbi.nlm.nih.gov/pubmed/32104583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goz065 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|